SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Bill Wexler's Profits of DOOM

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bill Wexler who wrote (1432)7/13/1998 8:38:00 AM
From: valueminded   of 4634
 
Bill

Thanks for info. I agree in terms of business can be catalyst. My question is you indicate that INTC is a long for you. It would seem to me with the current glut in competition, high valuation of INTC, and PC's becoming more and more a commodity item that it would be difficult to support a semiconductor company at 6x sales. Also, it seems that the revenue and earnings growth for INTC have slowed over the past 4 quarters and my expectation is for more of the same. I am sure you realize all this, my last reason for disliking INTC is that as recently as this year, it was considered to be the most liked stock among the mutual funds. Would appreciate your thoughts.

Thanks for recommendations on BGG, I tend to agree that they are going to have a difficult next few quarters.

Finally, (yes this is the message that never ends) I am evaluating Zonagen, as a possible short but wonder if if would be better to wait for their drug filing first. I see you are not enamored with Zonagen, my question is why would Schering put that kind of money into this company (57mil??) if the problems with the drug are so obvious? What am I missing ?

thanks
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext